Study of ALTO-101 in Patients With Schizophrenia
Trial details
- Registry ID
- NCT06502964
- Phase
- Phase 2
Drug identity checked against registry records
| Trial | Sponsor | Phase | Status | Primary completion |
|---|---|---|---|---|
| Study of ALTO-101 in Patients With SchizophreniaNCT06502964 | Alto Neuroscience | Phase 2 | Recruiting | 2026-02Estimated |
| No regulatory events match this view.This does not mean no FDA events have occurred. |